U.S. Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End-use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Biopsy Route
                        1.2.2. End-user
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in Italy
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Biopsy Route
                        2.2.2. End-use
                    2.3. Competitive Insights
Chapter 3. U.S. Fusion Biopsy Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                    3.3. Market Driver Analysis
                    3.4. Market Restraint Analysis
                    3.5. Industry Analysis - Porter’s Five Forces
                        3.5.1. Supplier power
                        3.5.2. Buyer power
                        3.5.3. Substitution threat
                        3.5.4. Threat of new entrant
                        3.5.5. Competitive rivalry
                    3.6. PESTEL Analysis
                        3.6.1. Political landscape
                        3.6.2. Technological landscape
                        3.6.3. Economic Landscape
Chapter 4. U.S. Fusion Biopsy Market: Biopsy Route Estimates & Trend Analysis
                    4.1. U.S. Fusion Biopsy Route Model Dashboard
                    4.2. U.S. Fusion Biopsy Market Biopsy Route Movement Analysis
                        4.2.1. Transrectal
                            4.2.1.1. Transrectal Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
                        4.2.2. Transperineal
                            4.2.2.1. Transperineal Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 5. U.S. Fusion Biopsy Market End-use Estimates & Trend Analysis
                    5.1. U.S. Fusion Biopsy End-use Model Dashboard
                    5.2. U.S. Fusion Biopsy Market End-use Movement Analysis
                        5.2.1. Hospitals
                            5.2.1.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.2.2. Diagnostic Centers
                            5.2.2.1. Diagnostic Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
                        5.2.3. Ambulatory care centers
                            5.2.3.1. Ambulatory care centers Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                        6.2.1. Vendor Landscape
                        6.2.2. List of key distributors and channel partners
                        6.2.3. Key customers
                        6.2.4. Key company market share analysis, 2023
                        6.2.5. ARTEMIS
                            6.2.5.1. Company overview
                            6.2.5.2. Financial performance
                            6.2.5.3. Product benchmarking
                            6.2.5.4. Strategic initiatives
                        6.2.6. KOELIS
                            6.2.6.1. Company overview
                            6.2.6.2. Financial performance
                            6.2.6.3. Product benchmarking
                            6.2.6.4. Strategic initiatives
                        6.2.7. Eigen Health
                            6.2.7.1. Company overview
                            6.2.7.2. Financial performance
                            6.2.7.3. Product benchmarking
                            6.2.7.4. Strategic initiatives
                        6.2.8. MedCom
                            6.2.8.1. Company overview
                            6.2.8.2. Financial performance
                            6.2.8.3. Product benchmarking
                            6.2.8.4. Strategic initiatives
                        6.2.9. Focal Healthcare
                            6.2.9.1. Company Overview
                            6.2.9.2. Financial performance
                            6.2.9.3. Product benchmarking
                            6.2.9.4. Strategic initiatives
                        6.2.10. BK Medical
                            6.2.10.1. Company Overview
                            6.2.10.2. Financial performance
                            6.2.10.3. Product benchmarking
                            6.2.10.4. Strategic initiatives
                        6.2.11. Agiliti Health
                            6.2.11.1. Company Overview
                            6.2.11.2. Financial performance
                            6.2.11.3. Product benchmarking
                            6.2.11.4. Strategic initiatives
                        6.2.12. Penn Medicine
                            6.2.12.1. Company Overview
                            6.2.12.2. Financial performance
                            6.2.12.3. Product benchmarking
                            6.2.12.4. Strategic initiatives
                        6.2.13. Cleveland Diagnostics
                            6.2.13.1. Company Overview
                            6.2.13.2. Financial performance
                            6.2.13.3. Product benchmarking
                            6.2.13.4. Strategic initiatives
                        6.2.14. PanGIA Biotech
                            6.2.14.1. Company Overview
                            6.2.14.2. Financial performance
                            6.2.14.3. Product benchmarking
                            6.2.14.4. Strategic initiatives
                        6.2.15. miR Scientific, Inc.
                            6.2.15.1. Company Overview
                            6.2.15.2. Financial performance
                            6.2.15.3. Product benchmarking
                            6.2.15.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. Fusion Biopsy, By Biopsy Route, 2018 - 2030 (USD Billion)
Table 3 U.S. Fusion Biopsy, By End-use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Fusion Biopsy Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Fusion Biopsy Market: Biopsy Route outlook and key takeaways
Fig. 15 Fusion Biopsy Market: Biopsy Route movement analysis & market share 2023 & 2030
Fig. 16 Transrectal market estimates and forecast, 2018 - 2030
Fig. 17 Transperineal market estimates and forecast, 2018 - 2030 Transducers market, 2018 - 2030 (USD Million)
Fig. 18 Fusion Biopsy Market: End-use outlook and key takeaways
Fig. 19 Fusion Biopsy Market: End-use movement analysis & market share
Fig. 20 Hospitals market, estimates and forecast, 2018 - 2030
Fig. 21 Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 22 Ambulatory Care Centres Market, 2018 - 2030 (USD Million)